Passage Bio, Inc.
PASG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34 | $55 | $75 | $339 |
| - Cash | $38 | $22 | $35 | $129 |
| + Debt | $25 | $26 | $27 | $0 |
| Enterprise Value | $22 | $60 | $68 | $210 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$4 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$62 | -$98 | -$132 | -$176 |
| % Margin | – | – | – | – |
| Net Income | -$65 | -$102 | -$136 | -$185 |
| % Margin | – | – | – | – |
| EPS Diluted | -21.44 | -37.29 | -50 | -69.51 |
| % Growth | 42.5% | 25.4% | 28.1% | – |
| Operating Cash Flow | -$48 | -$78 | -$118 | -$127 |
| Capital Expenditures | -$0 | -$0 | -$5 | -$26 |
| Free Cash Flow | -$48 | -$78 | -$123 | -$153 |